Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
George, S. R., et al. Nature Rev. Drug Discovery 1, 808–820 (2002).
Hoare, S. R. J. Drug Discovery Today 10, 417–427 (2005).
Drucker, D. J. Diabetes Care 26, 2929–2940 (2003).
Neer, R. M., et al. N. Engl. J. Med. 344, 1434–1441 (2001).
Bale, T. L. and Vale, W. W. Annu. Rev. Pharmacol. Toxicol. 44, 525–557 (2004).
Mesleh et al. J. Biol. Chem. 282, 6338–6346 (2007).
Thornton, K. and Gorenstein, D. G. Biochemistry 33, 3532–3539 (1994).
Tibaduiza, E. C., et al. J. Biol. Chem. 276, 37787–37793 (2001).
Acknowledgments
The work was supported by Welch Foundation (AT-1595), American Diabetes Association (7-07-JF-02), and Texas Advanced Research Program (009741-0031-2006).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this paper
Cite this paper
Ahn, JM., Han, SY., Murage, E., Beinborn, M. (2009). Rational Design of Peptidomimetics for Class B GPCRs: Potent Non-Peptide GLP-1 Receptor Agonists. In: Valle, S.D., Escher, E., Lubell, W.D. (eds) Peptides for Youth. Advances in Experimental Medicine and Biology, vol 611. Springer, New York, NY. https://doi.org/10.1007/978-0-387-73657-0_55
Download citation
DOI: https://doi.org/10.1007/978-0-387-73657-0_55
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-73656-3
Online ISBN: 978-0-387-73657-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)